Precision Pathology

CMS to Conduct Public Meeting on Genetic, Molecular Laboratory Test Billing

Changes in how the Medicare program will reimburse pathology groups and clinical laboratories for genetic tests and molecular diagnostic assays will be one of the important topics at an upcoming meeting in Baltimore. The federal Centers for Medicare and Medicaid Services will conduct the meeting at its headquarters and is asking for public comment as it develops coverage guidelines and reimbursement levels for the 2012 laboratory test fee schedule.

Click here for full article